HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of endogenous receptors for neoglycoproteins in Dunning R3327 rat prostatic carcinoma.

Abstract
An important animal model for human prostatic adenocarcinoma is the Dunning R3327 rat carcinoma. In the present study this tumor was further characterized by analyzing the expression of endogenous sugar-binding proteins using glycohistochemistry and immunocytochemistry as well as affinity chromatography and gel electrophoresis. Our glycohistochemical and glycobiochemical results provide evidence for the presence of specific receptors for various carbohydrate moieties. Remarkably, basal cells of the Dunning tumor contain an endogenous lectin with specificity for beta-galactosides that is not found in basal cells of the normal rat prostate. This finding was corroborated using polyclonal antibodies against an immunologically related beta-galactoside-specific lectin from bovine heart. Basal cells of prostatic carcinoma may therefore behave different from normal basal cells. This difference could have a significant impact on the development of prostatic cancer.
AuthorsF Sinowatz, H J Gabius, K P Hellmann, W Amselgruber, M R Schneider
JournalThe Prostate (Prostate) Vol. 16 Issue 2 Pg. 173-84 ( 1990) ISSN: 0270-4137 [Print] United States
PMID2320506 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glycoproteins
  • Platelet Glycoprotein GPIb-IX Complex
  • Platelet Membrane Glycoproteins
  • Receptors, Immunologic
  • glycoprotein receptor GPIb-IX
Topics
  • Animals
  • Binding Sites
  • Carcinoma (metabolism)
  • Chromatography, Affinity
  • Glycoproteins (metabolism)
  • Histocytochemistry
  • Immunohistochemistry
  • Male
  • Neoplasm Transplantation
  • Platelet Glycoprotein GPIb-IX Complex
  • Platelet Membrane Glycoproteins
  • Prostatic Neoplasms (metabolism)
  • Rats
  • Receptors, Immunologic (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: